Reuters logo
BRIEF-Hybio Pharmaceutical receives patent license
July 12, 2017 / 5:40 AM / 5 months ago

BRIEF-Hybio Pharmaceutical receives patent license

July 12(Reuters) - Hybio Pharmaceutical Co Ltd :

* Says co received a patent license (No.US 9,562,071 B2), named method for preparing eptifibatide

Source text in Chinese: goo.gl/8Uob6m

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below